In melanoma, the presence of lymphocytes has been demonstrated to be closely associated with the expression of a well-defined chemokine signature, including CCL2, CCL4, CCL5, CXCL9, CCL19, CCL21, CXCL10, CXCL11, CXCL13, and XCL2. This evidence concerns the gene CCL5 and melanoma.